Cheryl Jackson

Title: Cheryl Jackson: Innovator in Therapeutic Delivery Systems

Introduction

Cheryl Jackson is a prominent inventor based in Hoover, AL (US). She has made significant contributions to the field of therapeutic delivery systems, particularly through her innovative work involving poliovirus replicons. Her research focuses on methods that can potentially revolutionize the treatment of various diseases.

Latest Patents

Cheryl Jackson holds a patent for "Poliovirus replicons encoding therapeutic agents and uses thereof." This invention pertains to methods of delivering a polypeptide to a cell. The process involves contacting a cell with a replicon that has a non-poliovirus nucleic acid substituted for a nucleic acid encoding a protein necessary for encapsidation. The non-poliovirus nucleic acid encodes, in an expressible form, a polypeptide or fragment thereof. The methods may be used to treat diseases, including central nervous system disorders, infectious diseases, and cancer.

Career Highlights

Cheryl Jackson is affiliated with The University of Alabama, where she continues her research and development in the field of therapeutic agents. Her work has garnered attention for its potential applications in medicine and healthcare.

Collaborations

Cheryl collaborates with notable colleagues, including Casey D Morrow and Jean Peduzzi. These partnerships enhance her research efforts and contribute to the advancement of therapeutic delivery systems.

Conclusion

Cheryl Jackson's innovative work in the field of therapeutic delivery systems showcases her commitment to advancing medical science. Her patent on poliovirus replicons highlights her contributions to potential treatments for serious diseases.